Cocrystal Pharma Inc. Revenue 2011–2020
Cocrystal Pharma Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cocrystal Pharma Inc. revenue for the quarter ending March 31, 2026 was 225000, a 51.19% decrease year-over-year.
- Cocrystal Pharma Inc. revenue for the twelve months ending March 31, 2026 was 1.7 M, a 71.94% decrease year-over-year.
- Cocrystal Pharma Inc. annual revenue for 2020 was 2.0 M, a 69.32% decrease from 2019.
- Cocrystal Pharma Inc. annual revenue for 2019 was 6.6 M, a 48.36% decrease from 2011.
- Cocrystal Pharma Inc. annual revenue for 2011 was 12.7 M.
Cocrystal Pharma Inc. (COCP) — Frequently Asked Questions
Cocrystal Pharma Inc. (COCP) is a publicly traded US company. It has a market capitalization of $70M. In fiscal 2020 it reported revenue of $2M and net income of -$10M. Explore COCP's stock price, financial statements, earnings history, margins and key ratios below.
What is Cocrystal Pharma Inc.'s market cap?
Cocrystal Pharma Inc. (COCP) has a market capitalization of $70M.
What is the COCP stock price?
COCP trades at $1.00 (-1.96% on the day).
How much revenue does Cocrystal Pharma Inc. make?
Cocrystal Pharma Inc. reported revenue of $2M in fiscal 2020.
Is COCP profitable?
In fiscal 2020, Cocrystal Pharma Inc. reported net income of -$10M.